Arcus Biosciences: Casdatifan Takes Center Stage After STAR-221 (NYSE:RCUS)

Core Insights - Arcus Biosciences, Inc. (RCUS) is a biopharmaceutical company focused on developing drugs intended for use in combination with other agents rather than as standalone treatments [1] Group 1: Company Overview - RCUS is undergoing a strategic reset following the discontinuation of its previous projects [1]